glp-1 receptor agonists cardiovascular benefits Discover the Game-Changing of ๐ From sustainable weight loss and better blood sugar control to heart health and reduced cravings โ GLP-1 are transforming lives. ๐ Now available GLP-1 receptor agonists show promise
Description
Short acting agents (such as exenetide) exert their effect mostly by slowing gastric emptying, which reduces post-prandial glucose levels

NICE guidance (NG28) recommends considering GLP-1 receptor agonists for adults with type 2 diabetes when glycaemic targets are not achieved with other therapies, particularly in those with established cardiovascular disease or at high cardiovascular risk

Although diabetic patients commonly use metformin, GLP-1R agonists serve as a beneficial therapeutic option for diabetic patients with metformin intolerance

Body composition in anorexia nervosa: Meta-analysis and meta-regression of cross-sectional and longitudinal studies
These medications now account for more than 15 percent of annual claims for more than a quarter of employers

To understand why these therapies have attracted attention in longevity research, it is useful to first examine the scientific framework that describes the biological processes underlying aging